COMPARE CPM-RMI Trial: Intramyocardial Transplantation of
Autologous Bone Marrow-Derived CD133+ Cells and MNCsduring CABG in Patients with Recent MI: A Phase II/III,Multicenter, Placebo-Controlled, Randomized,Double-Blind Clinical Trial. This evidence concerns the gene PROM1 and myocardial infarction.